Skip to main content
. Author manuscript; available in PMC: 2012 Nov 3.
Published in final edited form as: Neurology. 2006 Sep 12;67(5):834–842. doi: 10.1212/01.wnl.0000234032.77541.a2

Table 2.

Participant characteristics

HC group, n = 40 CC group, n = 40 MCI group, n = 40 p (post hoc differences)
Age, y 71.0 (5.1) 73.3 (6.0) 72.9 (7.1) NS
Education, y 16.6 (2.7) 16.4 (2.8) 16.3 (3.3) NS
Sex (M/F) 12/28 16/24 23/17 0.042
APOE E4 (−/+)* 24/16 31/9 20/18 0.063
ANART, est. of verbal IQ 122.8 (4.7) 120.7 (6.3) 120.7 (6.6) NS
Barona FSIQ est. 116.1 (5.6) 116.2 (5.4) 115.8 (6.1) NS
MMSE (max. 30) 29.1 (1.0) 28.9 (1.2) 27.2 (2.2) <0.001**
DRS total score (max. 144) 141.0 (2.1) 141.3 (2.4) 137.0 (4.6) <0.001**
CVLT Total 1–5 (max. 80) 48.6 (6.8) 47.1 (8.6) 32.6 (6.0) <0.001**
Short delay (max. 16) 11.2 (1.9) 10.4 (2.4) 5.4 (2.7) <0.001**
Long delay (max. 16) 11.8 (2.0) 10.5 (2.8) 5.6 (2.7) <0.001**
WMS-III LM immediate (max. 75) 48.0 (7.4) 45.6 (8.2) 33.6 (8.5) <0.001**
LM delay (max. 50) 31.6 (6.1) 28.4 (6.8) 18.8 (7.9) <0.001**
Verbal memory§
Composite (Z) 0.01 (0.62) −0.36 (0.79) −2.24 (0.76) <0.001**
Tests below cutoff 0.35 (0.74) 0.85 (1.05) 3.58 (1.39) <0.001**
CC scales
 Overall CCI (%) 9.8 (6.4) 30.0 (9.5) 34.8 (13.9) <0.001§§
 Squire Memory (max. 18) 5.3 (3.5) 11.0 (3.8) 11.3 (4.4) <0.001§§
 ADL self (max. 54) 3.2 (3.0) 12.7 (6.7) 14.4 (9.6) <0.001§§
 ADL informant (max. 54) 1.7 (2.2) 8.0 (7.6) 13.2 (10.6) <0.001††
 IQCODE self (max. 16) 1.6 (2.3) 5.5 (3.0) 5.8 (3.5) <0.001§§
 IQCODE informant (max. 16) 2.2 (1.2) 3.9 (2.4) 5.3 (3.2) <0.002‡‡
 GDS cognitive items (max. 4) 0.4 (0.8) 2.0 (1.1) 2.1 (1.3) <0.001§§
 Memory interview (max. 10) 2.2 (1.7) 4.4 (1.9) 5.2 (2.5) <0.001§§
 MAQ (max. pace 23) 2.0 (1.6) 4.0 (2.0) 4.8 (1.9) <0.001§§
 GDS-NC (max. 26) 1.8 (2.5) 3.6 (3.1) 3.5 (3.2) <0.01§§
 HAM-D61# 0.1 (0.3) 1.1 (1.8) 1.2 (2.0) NS
 Hachinski Ischemia score62 (max. 18) 1.4 (0.5) 1.3 (0.5) 1.3 (0.5) NS
 Revised Ischemia score63 (max. 52)|| 4.6 (0.9) 4.7 (1.1) 4.7 (1.3) NS
*

APOE data missing for two participants in MCI group.

Demographically based estimate of full-scale IQ.53

California Verbal Learning Test-I/II, Total Learning Trials 1 through 5 (maximum 80), short and long delay free recall (maximum 16 per trial).

§

Composite is the mean age, education and sex adjusted Z score for the five verbal memory measures; tests below cutoff is the number of verbal memory tests out of five that fell ≥1.5 SDs below control group mean.

Cognitive Complaint Index (CCI), percentage of all complaint items endorsed in a positive (i.e., symptomatic) direction. See text for references for the component scales.

#

Available for 43 participants (HCs, 15; CCs 16; MCI, 12).

||

Available for 96 participants (HCs, 29, CCs, 34, MCI, 33).

For analyses of variance post hoc group contrasts:

**

MCI vs HCs, CCs;

††

MCI vs CC vs HC;

‡‡

MCI vs HCs;

§§

MCI, CC vs HC with direction indicated by the table values. For sex, χ2 differed for HCs vs MCI only. For APOE, MCI had a higher frequency of the E4 allele than CCs.

HC = healthy control; CC = cognitive complaint; MCI = mild cognitive impairment; NS = not significant; ANART = American National Adult Reading Test; FSIQ = full-scale IQ; MMSE = Mini-Mental State Examination; DRS = Dementia Rating Scale-2; CVLT = California Verbal Learning Test-I/II; WMS-III = Wechsler Memory Scale III; LM = logical memory; CCI = Cognitive Complaint Index; ADL = activities of daily living; IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly; GDS = Geriatric Depression Scale; MAQ = Memory Assessment Questionnaire; GDS-NC = Geriatric Depression Scale noncognitive items; HAM-D = Hamilton Rating Scale for Depression.